• Start
  • News
  • Studio
  • Events
  • Analyses
  • Newsletter
  • Mobile app
  • About BioStock
    • Contact us
    • Career
  • Swedish
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
BioStock - Aktieanalyser & nyheter BioStock
BioStock - Aktieanalyser & nyheter
  • Start
  • News
  • Studio
  • Events
  • Analyses
  • Newsletter
  • Mobile app
  • About BioStock
    • Contact us
    • Career
  • Swedish
Abliva secures financing

Abliva secures funding to advance KL1333 into phase II/III

3 June, 2022
BioStock intervjuar Abliavs vd Ellen Donnelly via link

Abliva on the 200 MSEK financing round

1 June, 2022
Promore Pharmas Q1 studieavancemang

Promore Pharma’s Q1 characterised by study progress

25 May, 2022
Promore Pharma leg wounds

Promore Pharma aims to accelerate healing of venous leg ulcers

16 May, 2022

BioStock’s article series on drug development: Making Treatments More Accessible

10 October, 2019

THE BIOSTOCK NEWSLETTER

The latest insights straight to your inbox

"*" indicates required fields

* Required fields
This field is for validation purposes and should be left unchanged.

biostock_news BioStock News @biostock_news ·
1 Jul

CEO Dorte X. Gram increases holding in Pila Pharma

#PilaPharma #LifeSciences #BioStockSwe

https://mfn.se/beq/a/pila-pharma/ceo-dorte-x-gram-increases-holding-in-pila-pharma-ab-32b58e94

Reply on Twitter 1542843480417918978 Retweet on Twitter 1542843480417918978 Like on Twitter 1542843480417918978 Twitter 1542843480417918978
biostock_news BioStock News @biostock_news ·
1 Jul

Alzinova: Conversion of BTU into shares and warrants of series TO3

#Alzinova #LifeSciences #BioStockSwe

https://mfn.se/cis/a/alzinova/alzinova-conversion-of-btu-into-shares-and-warrants-of-series-to3-eac30a04

Reply on Twitter 1542820332293300225 Retweet on Twitter 1542820332293300225 Like on Twitter 1542820332293300225 Twitter 1542820332293300225
biostock_news BioStock News @biostock_news ·
1 Jul

Saniona reports positive top line results from the SAN711 Phase 1 Clinical Trial

#Saniona #LifeSciences #BioStockSwe

https://mfn.se/one/a/saniona/saniona-reports-positive-top-line-results-from-the-san711-phase-1-clinical-trial-3148ba6f

Reply on Twitter 1542755480707420160 Retweet on Twitter 1542755480707420160 Like on Twitter 1542755480707420160 Twitter 1542755480707420160
Ladda fler
BioStock

BioStock is the leading digital news and analytics service in the Nordics, focusing exclusively on the life science sector.

OFFICE

Lund
Medicon Village, The Spark
Scheeletorget 1
223 81 Lund

Stockholm
Kungsgatan 33
111 56 Stockholm

BIOSTOCK

About BioStock
Career
Contact us

Cookie settings
© BioStock 2022
This website uses cookies to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept" you consent to the use of ALL cookies. You may also visit "Cookie-settings" to adjust your consent in detail.
Cookie settingsAcceptRead More
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Functional
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Advertisement
Others
Save & Accept
Powered by CookieYes Logo